Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Cai, Li  [Clear All Filters]
2015
Qiao B, Shui W, Cai L, Guo S, Jiang D. Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. Drug Des Devel Ther. 2015;9:969-76.
2019
Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T, Howard L, Cai L, Shen S. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A). Stem Cell Res. 2019;43:101665.
Anderson J, Patel M, Ai X, Cai C, Wade Q, Risman R, Cai L. A novel mouse model for the study of endogenous neural stem and progenitor cells after traumatic brain injury. Exp Neurol. 2019:113119.
2021
Rathnam C, Yang L, Castro-Pedrido S, Luo J, Cai L, Lee K-B. Hybrid SMART spheroids to enhance stem cell therapy for CNS injuries. Sci Adv. 2021;7(40):eabj2281.
Patel M, Anderson J, Lei S, Finkel Z, Rodriguez B, Esteban F, Risman R, Li Y, Lee K-B, Lyu YLisa, et al. Nkx6.1 enhances neural stem cell activation and attenuates glial scar formation and neuroinflammation in the adult injured spinal cord. Exp Neurol. 2021:113826.
2022
Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T, Howard L, Cai L, Shen S. Corrigendum to "Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)" [Stem Cell Res. (43) 2020 101665]. Stem Cell Res. 2022;63:102850.